<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220920055995N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-27</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Mediterranean diet and the traditional food recommendation on fatigue and depression in multiple sclerosis</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of the nutritional recommendations based on Mediterranean diet and the traditional food recommendation to reduce the fatigue severity and depressive symptoms in patients with multiple sclerosis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65991</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: A randomized block design will be used. The random sequence will be generated using the online software ( Create a blocked randomization list | Sealed Envelope). We will use blocks with sizes of 3, 6, and 12.

 In addition, a fully sealed envelope covered with carbon paper will be used to conceal the allocation. The statistics specialist will prepare the concealment envelopes, which will remain hidden until the grouping training course is held, Blinding description: Stages of study blinding:

Both participants and researchers or outcome assessors in this study are unaware of study group allocation. 

Everyone involved in the study assumed that all three groups of participants would receive the educational intervention.

The clinical caregiver will conduct educational sessions for all patients, introduce the study groups in general, and explain the study's objectives to the patients. The patient-educator and the duration-place will be the same. The educational counseling structure will be the same for all patients, but educational clauses corresponding to the intervention group will be added to the educational structure in the first, second, and third intervention groups. The clinical caregiver is unaware of the patient grouping.

The neurologist introduces the patients to the research group after assessing their eligibility for participation in the study. The neurologist has no concept which patients belong to which groups.

Based on the block randomization, the clinical supervisor of the study will assign patients to the first, second, and third groups, and then complete fatigue and depression assessment questionnaires for all patients.

In the first group, a clinical caregiver  will assess patients' adherence to the Mediterranean diet, and then the patient will receive specialized training in the field of increasing adherence to the Mediterranean diet. The patient will also be given an educational pamphlet. This group's clinical caregiver is unaware of the second and third groups.

In the second intervention group, a clinical caregiver will first complete the three-day food record questionnaire before providing patients with dietary recommendations based on food traditional medicine (nature of food).This group's clinical caregiver is unaware of the first and third groups.

The final group (control group) receives general healthy nutritional advice from a clinical caregiver. This group's clinical caregiver is unaware of the first and second groups.

After 8 weeks, the second researcher will complete the main outcome of the study, the fatigue and depression assessment questionnaire for all patients, without knowing the grouping of the participants, and enter the data into the software.

A statistician will analyze the data. The statistician is unaware of the study's grouping. 

Based on the analysis, the primary researcher of the study will draft the article. The primary researcher is aware of the grouping.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Multiple sclerosis.</hc_freetext>
      <i_freetext>Intervention 1: The first intervention group: During two months, patients participate twice in a 20-minute consultation program with the content of the principles of the Mediterranean diet. It will be taught using the Mediterranean diet questionnaire, a 13-question universal questionnaire. The Mediterranean diet emphasizes daily consumption of olives and olive oil, nuts, a high intake of legumes, grains including potatoes and bread, fruits and vegetables, a low consumption of red meat and meat products, and a moderate consumption of milk and dairy products. Patients will be educated on the 13 recommendations and given an educational pamphlet. It is recommended, for example, how many olives to eat per day, how many fruits to eat, and which foods to avoid. At first, the study will use a questionnaire to determine adherence to the Mediterranean diet. Intervention 2: The second intervention group: During two months, patients participate twice in a 20-minute consultation program with the content of the principles of traditional medicine's food pattern (hot and cold foods). 4 Dietary recommendations will be given to patients based on the findings of Sharifi et al.'s study of the dietary pattern in MS patients in Shiraz and the Rezapour study in Tehran. The four important dietary recommendations are as follows: consume two units of nuts per day, only one unit of sweets per day, four units of hot fruits per day, and avoid flavors such as vinegar and pickles. Patients will be  given an educational pamphlet. Intervention 3: The control group: During a two-month period, patients participate twice in a 20-minute counseling program with the content of healthy eating principles. All patients in this group will receive routine general nutrition education. For example, less salt and low-fat food consumption, less fast food consumption, and a regular physical activity program.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It is not necessary. It will be sent to other researchers if needed</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Hossein Sharifi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz School of Medicine, Imam Hossein Square, Zand St., -Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7134845794</zip>
        <telephone>+98 71 3208 4028</telephone>
        <email>mhsharifi1350@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Hossein Sharifi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz School of Medicine, Imam Hossein Square, Zand St., Shiraz, Iran</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7134845794</zip>
        <telephone>+98 71 3208 4028</telephone>
        <email>mhsharifi1350@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with definite diagnosis of multiple sclerosis
Kurtzke Extended disability status score  &lt; 6
Complete the consent form for the research survey</inclusion_criteria>
      <agemin>16 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with secondary or primary progressive multiple sclerosis
Patient with pregnancy
Patient receives corticosteroid drug.
Patient has cardiovascular disease.
Patient has malignant tumors.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G35</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Multiple sclerosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The first intervention group: During two months, patients participate twice in a 20-minute consultation program with the content of the principles of the Mediterranean diet. It will be taught using the Mediterranean diet questionnaire, a 13-question universal questionnaire. The Mediterranean diet emphasizes daily consumption of olives and olive oil, nuts, a high intake of legumes, grains including potatoes and bread, fruits and vegetables, a low consumption of red meat and meat products, and a moderate consumption of milk and dairy products. Patients will be educated on the 13 recommendations and given an educational pamphlet. It is recommended, for example, how many olives to eat per day, how many fruits to eat, and which foods to avoid. At first, the study will use a questionnaire to determine adherence to the Mediterranean diet.</i_keyword>
      <i_keyword>The second intervention group: During two months, patients participate twice in a 20-minute consultation program with the content of the principles of traditional medicine's food pattern (hot and cold foods). 4 Dietary recommendations will be given to patients based on the findings of Sharifi et al.'s study of the dietary pattern in MS patients in Shiraz and the Rezapour study in Tehran. The four important dietary recommendations are as follows: consume two units of nuts per day, only one unit of sweets per day, four units of hot fruits per day, and avoid flavors such as vinegar and pickles. Patients will be  given an educational pamphlet</i_keyword>
      <i_keyword>The control group: During a two-month period, patients participate twice in a 20-minute counseling program with the content of healthy eating principles. All patients in this group will receive routine general nutrition education. For example, less salt and low-fat food consumption, less fast food consumption, and a regular physical activity program.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Fatigue score in Krupp Fatigue Severity Questionnaire. Timepoint: At the beginning of the study and then 60 days after the intervention. Method of measurement: Fatigue Severity Scale ‎Krupp.</prim_outcome>
      <prim_outcome>Depression score from Beck depression questionnaire - short form. Timepoint: At the beginning of the study and then 60 days after the intervention. Method of measurement: Beck depression questionaire -short form.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-09</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Shiraz School of Medicine, Imam Hossein Square  Zand St., Shiraz, Iran Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
